BDR Pharmaceuticals, a leading pharmaceutical firm has announced the launch of Nilotinib to treat a rare subtype of acute lymphoblastic leukaemia, the most common childhood cancer.PH+ leukaemia, which includes acute lymphoblastic leukaemia (ALL)....
Venus Remedies, a global provider of affordable cancer drugs, has strengthened its position in the Gulf Cooperation Council (GCC), Association of South East Asian Nations (ASEAN), Balkan, and Caribbean regions with marketing approvals...
The Foreign Direct Investment (FDI) equity inflow into the pharmaceutical industry has registered a growth of 45.4 per cent in the fiscal year ended March, 2023, as compared to the inflow in the previous fiscal year. The foreign equity investment ...
Nutra Prep, a new sports nutrition startup, and Nutrabolt, a globally recognised leader in the active health and wellness industry, have signed a strategic agreement for Nutrabolt's 'C4' and 'Xtend' brand products to be manufactured...
Biocon Biologics Ltd announced that HULIO injection, a biosimilar to Humira , is now available to patients in the US after five years of experience in Europe and two years in Canada. HULIO meets the rigorous biosimilar approval standards of the...
Even Healthcare, a prominent healthcare provider based in Bengaluru, and Healthily, a digital health business based in London, have established a strategic partnership to provide comprehensive and data-driven preventative healthcare services...
According to LSEG Deals Intelligence, deal making in the healthcare sector accounts for 14% of global M&A so far this year, with US$ 174.6 billion in announced deals, up 35% from last year and a two-year high...
The European Commission announced on Friday that it has reached agreements with Pfizer and several European drugmakers to reserve capacity to produce up to 325 million vaccines per year in the event of a future global health emergency....
Ajanta Pharma is looking to expand its presence in certain geographies with significant development potential in Asia and Africa as part of its growth strategy. The Mumbai-based drugmaker indicated in its Annual Report for 2022-23 that it plans....
Global Hospital in Parel, Mumbai, has announced the commencement of its new robot-assisted heart surgery programme, which aims to reduce recovery time and problems for patients undergoing delicate heart surgery...
, CDSCO.jpg)
